Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)

Sánchez Henarejos, Pilar; Ros Martínez, Silverio; Marín Zafra, Gema R.; Alonso-Romero, José Luis; Navarrete Montoya, Agustín

Publication:
Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)

dc.contributor.author	Sánchez Henarejos, Pilar
dc.contributor.author	Ros Martínez, Silverio
dc.contributor.author	Marín Zafra, Gema R.
dc.contributor.author	Alonso-Romero, José Luis
dc.contributor.author	Navarrete Montoya, Agustín
dc.contributor.department	Medicina
dc.date.accessioned	2024-11-07T13:14:13Z
dc.date.available	2024-11-07T13:14:13Z
dc.date.copyright	© 2009, Feseo
dc.date.issued	2009-07
dc.description.abstract	Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and can be severe. Here we provide a case report of a patient who developed an intertrigolike eruption during treatment with PLD.	es
dc.format	application/pdf	es
dc.format.extent	2	es
dc.identifier.citation	Clin Transl Oncol (2009) 11:486-487
dc.identifier.doi	https://doi.org/10.1007/s12094-009-0390-2
dc.identifier.issn	Print: 1699-048X
dc.identifier.issn	Electronic: 1699-3055
dc.identifier.uri	http://hdl.handle.net/10201/146094
dc.language	eng	es
dc.publisher	Springer
dc.relation	Sin financiación externa a la Universidad	es
dc.relation.publisherversion	https://link.springer.com/article/10.1007/s12094-009-0390-2
dc.rights.accessRights	info:eu-repo/semantics/restrictedAccess
dc.subject	Liposomes	es
dc.subject	Anthracyclines	es
dc.subject	Breast carcinoma	es
dc.subject	Dermatologic toxicity	es
dc.title	Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)	es
dc.type	info:eu-repo/semantics/article	es
dc.type.version	info:eu-repo/semantics/publishedVersion
dspace.entity.type	Publication	es